FIELD: biotechnology; biophysics; molecular biology; medicine; veterinary medicine.
SUBSTANCE: invention can be used in the treatment of various neoplasms, as well as various intracellular infections of humans and animals. The invention is developing a method of preventing inactivation of cell death caused by cytochrome C by exposing unwanted cells to micro-, Piwi-interacting or small interfering RNAs that suppress the expression of heat shock protein-27, and cytochrome C.
EFFECT: invention is effective for increasing the efficiency of destruction of unwanted cells.
1 cl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT AND METHOD FOR APOPTOSIS INDUCTION IN CANCER CELLS | 2012 |
|
RU2488408C1 |
| METHOD FOR PREDICTION OF DEVELOPING ACUTE RENAL FAILURE BY LEVEL OF EXPRESSION OF GENES CASP3, CASP8 AND CASP9 AFTER SHORT-TERM KIDNEY ISCHEMIA | 2015 |
|
RU2599099C1 |
| 2-AMINO-1-(4-BROMOPHENYL)-5-(3,3-DIMETHYL-2-OXOBUTYLIDENE)-4-OXO-4,5-DIHYDRO-1H-PYRROL-3-CARBOXAMIDE EXHIBITING CYTOTOXIC ACTIVITY AGAINST HUMAN TUMORAL CELLS | 2020 |
|
RU2753480C1 |
| AGENT POSSESSING APOPTOSIS-INHIBITING ACTIVITY | 2018 |
|
RU2677877C1 |
| BIOMARKERS OF DEVELOPING COMPLICATIONS OF INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS | 2019 |
|
RU2720110C1 |
| AGENT FOR STIMULATING PROLIFERATIVE ACTIVITY OF BONE MARROW CELLS | 2023 |
|
RU2811901C1 |
| MEANS FOR PREPARATION OF ANTIMICROBIAL THERAPEUTIC SOLUTION (OPTIONS), METHOD FOR ORGANIZATION OF MEANS FOR PREPARATION OF ANTIMICROBIAL THERAPEUTIC SOLUTION (OPTIONS) | 2020 |
|
RU2779613C2 |
| AGENT WITH ANTIAPOPTOTIC ACTIVITY | 2018 |
|
RU2685428C1 |
| RECOMBINANT ADEN-ASSOCIATED VIRUS, WHICH IS HYBRID OF AAV9 AND AAVrh74 SEROTYPES, WITH REDUCED TROPISM FOR LIVER TISSUE | 2019 |
|
RU2812279C2 |
| METHOD FOR PREVENTION OF ANTIMICROBIAL PROTECTION DISORDERS IN PATIENTS OPERATED ON FOR CURVATURE OF NASAL SEPTUM USING ULTRASONIC CAVITATION AND PHOTOCHROMOTHERAPY | 2019 |
|
RU2715456C1 |
